Biomimetic gold nanocages incorporating copper-human serum albumin for tumor immunotherapy via cuproptosis-lactate regulation
Journal of Controlled Release · 2024-08 · 372 · 446-466
DOI: 10.1016/j.jconrel.2024.06.059 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Controlled Release, 2024-08. Verfasst von Hajra Zafar und 6 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Frontiers Science Center of Drug Target Identification and Delivery, School of Pharmaceutical Sciences, Shanghai Jiao Tong University, 800 D…. Hauptthemen laut MEDLINE: Gold, Copper, Immunotherapy, Serum Albumin, Human. Die Arbeit wurde bisher 57-mal zitiert (Crossref) und nennt 65 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shanghai Frontiers Science Center of Drug Target Identification and Delivery, School of Pharmaceutical Sciences, Shanghai Jiao Tong University, 800 Dongchuan Road, Shanghai 200240, China.
- Shanghai Frontiers Science Center of Drug Target Identification and Delivery, School of Pharmaceutical Sciences, Shanghai Jiao Tong University, 800 Dongchuan Road, Shanghai 200240, China.. Electronic address: qshen@sjtu…
Zitieren
APA
Zafar, H., Zhang, J., Raza, F., Pan, X., Hu, Z., Feng, H., & Shen, Q. (2024). Biomimetic gold nanocages incorporating copper-human serum albumin for tumor immunotherapy via cuproptosis-lactate regulation. Journal of Controlled Release, 372, 446-466. https://doi.org/10.1016/j.jconrel.2024.06.059
Vancouver
Zafar H, Zhang J, Raza F, Pan X, Hu Z, Feng H, et al. Biomimetic gold nanocages incorporating copper-human serum albumin for tumor immunotherapy via cuproptosis-lactate regulation. Journal of Controlled Release. 2024;372:446-466. doi:10.1016/j.jconrel.2024.06.059
BibTeX
@article{Zafar2024,
author = {Zafar, Hajra and Zhang, Jun and Raza, Faisal and Pan, Xiuhua and Hu, Zongwei and Feng, Hanxiao and Shen, Qi},
title = {Biomimetic gold nanocages incorporating copper-human serum albumin for tumor immunotherapy via cuproptosis-lactate regulation},
journal = {Journal of Controlled Release},
year = {2024},
volume = {372},
pages = {446--466},
doi = {10.1016/j.jconrel.2024.06.059}
}
EUVIMED